Vast release of submaxillary mouse renin to saliva after stimulation with cholinergic, beta-adrenergic but especially alpha-adrenergic agonists.
alpha-adrenergic stimulation with phenylephrine causes release of vast amounts of mouse submaxillary gland renin to saliva. The amount released is about 100-fold higher than that released after beta-adrenergic stimulation with isoproterenol and about 1000-fold higher than the amount released after cholinergic stimulation with pilocarpine. alpha-blockade with phenoxybenzamine before phenylephrine stimulation strongly inhibits the renin release. However, phenoxybenzamine or beta-blockade with propranolol before isoproterenol stimulation have no effect on the amount of renin released. Thus, the release of submaxillary mouse renin to saliva is triggered mainly by activation of alpha-adrenergic receptors. Renin in cholinergic and alpha- and beta-adrenergic stimulated saliva has the same molecular weight and the same specific enzymatic activity as renin in the submaxillary gland. This indicates that renin is secreted to saliva, and probably also to the blood, in its fully enzymically active 40000 mol.wt. form regardless of the stimulus used. The vast amounts of renin released to saliva (up to 600 Goldblatt Units) demonstrate that submaxillary mouse renin is secreted predominantly to saliva and much less to the blood. The mouse submaxillary gland therefore seems to have an exocrine rather than an endocrine role for release of renin.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002850:Chromatography, Gel; D008297:Male; D051379:Mice; D010277:Parasympathomimetics / Q000494:pharmacology*; D012083:Renin / Q000032:analysis / Q000378:metabolism*; D012463:Saliva / Q000032:analysis; D012472:Salivation / Q000187:drug effects; D013363:Submandibular Gland / Q000378:metabolism*
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D010277:Parasympathomimetics; D012083:Renin